Rev Ig Med Muncii Med Soc Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
December 1991
The investigation was carried out in 125 patients with pulmonary tuberculosis in different stages of evolution. The treatment was that granted, used in triple and/or quadruple scheme twice a week. In the greatest part of the patients the concentration of serum fibronectine (sFN) was followed in its dynamics.
View Article and Find Full Text PDFRev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
January 1989
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
January 1989
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
February 1986
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol
December 1983
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol
August 1981
The study was carried out in 105 patients with pulmonary tuberculosis undergoing treatment with 900 mg of rifampicin in association with 1 or 2 tuberculostatics. The drugs were given twice weekly. Between 1 and 3 investigations were performed in each patient, using the method introduced by Poole for the detection of anti-RMP antibodies.
View Article and Find Full Text PDFRev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna
August 1981